New variant Creutzfeldt-Jakob disease: Neurological features and diagnostic tests

Lancet

Volumn 350, Issue 9082, 1997, Pages 903-907

  Zeidler, M ^a   Stewart, G E ^a   Barraclough, C R ^a   Bateman, D E ^a   Bates, D ^a   Burn, D J ^a   Colchester, A C ^a   Durward, W ^a   Fletcher, N A ^a   Hawkins, S A ^a   Mackenzie, J M ^a   Will, R G ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ADOLESCENT; ADULT; AKINETIC MUTISM; ARTICLE; ATAXIA; BOVINE SPONGIFORM ENCEPHALOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DEPRESSION; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAM; FEMALE; FRANCE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; INVOLUNTARY MOVEMENT; MALE; MENTAL DISEASE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SENSORY NEUROPATHY; THALAMUS; UNITED KINGDOM;

EID: 0031588178     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)07472-2     Document Type: Note

References (38)

1. 1 Department of Health. New variant Creutzfeldt-Jakob disease. CMO's Update 1997; 13: 4.
2. 2 Chazot G, Broussolle E, Lapras Cl, et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996; 347: 1181.
3. 3 Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-25.
4. 4 Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
5. 5 Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. 1: Clinical features. J Neurol Neurosurg Psychiatry 1984; 47: 134-40.
6. 6 Brown P, Cathala F, Gajdusek DC. Creutzfeldt-Jakob disease in France: III. Epidemiological study of 170 patients dying during the decade 1968-1977. Ann Neurol 1979; 6: 438-46.
7. 7 Brown P, Cathala F, Sadowsky D, et al. Creutzfeldt-Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968-1977. Ann Neurol 1979; 6: 430-37.
8. 8 Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 1995; 5: 459-66.
9. 9 Brown P. Clinical neurology and epidemiology of Creutzfeldt-Jakob disease, with special reference to iatrogenic cases. In: Bock G, Marsh J, eds. Novel infectious agents of the central nervous system, Chichester: Wiley, 1988: 3-23.
10. 10 Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-30.
11. 11 Hornabrook RW, Wagner F. Creutzfeldt-Jakob disease. Papua New Guinea Medical Journal 1975; 18: 226-28.
12. 12 Packer RJ, Cornblath DR, Gonatas NK, et al. Creutzfeldt-Jakob disease in a 20-year-old woman. Neurology 1980; 30: 492-96.
13. 13 Monreal J, Collins GH, Masters CL, et al. Creutzfeldt-Jakob disease in an adolescent. J Neurol Sci 1981; 52: 341-50.
14. 14 Raverdy P, Hauw JJ, Cathala F, et al. Creutzfeldt-Jakob disease of 34 month's development in a 26-year-old woman. Revue Neurologique 1983; 139: 381-83.
15. 15 Brown P, Cathala F, Labauge R, et al. Epidemiologic implications of Creutzfeldt-Jakob disease in a 19-year-old girl. European J Epid 1985; 1: 42-47.
16. 16 Kulczycki J, Jedrzejowska H, Gajkowski K, et al. Creutzfeldt-Jakob disease in young people. European J Epid 1991; 7: 501-04.
17. 17 Berman P, Davidson GS, Becker LE. Progressive neurological deterioration in a 14-year-old girl. Pediatr Neurosci 1988; 14: 42-49.
18. 18 Zeidler M, Johnstone EC, Bomber RWK, et al. New variant Creutzfeldt disease: psychiatric feature. Lancet 1997; 350: 908-10.
19. 19 Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.
20. 20 de Silva RN, Patterson J, Russell A, et al. HMPAO-SPECT in the identification of new variant CJD. BMJ (in press).
21. 21 Lasmezas CI, Deslys JP, Demalmay R, et al. BSE transmission to macaques. Nature 1996; 381: 743-44.
22. 22 Collinge J, Sidle KCL, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-90.
23. 23 Kimberlin RH. Transmissible encephalopathies in animals. Can J Vet Res 1990; 54: 30-37.
24. 24 Bruce M, Chree A, McConnell I, et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philosophical Transactions of the Royal Society of London-Series B: Biological Sciences 1994; 343: 405-11.
25. 25 Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806-08.
26. 26 Deslys JP, Lasmezas CI, Jaegly A, et al. Growth hormone-related Creutzfeldt-Jakob disease: genetic susceptibility and molecular pathogenesis. In: Court L, Dodet B, eds. Transmissible subacute spongiform encephalopathies: prion diseases. Paris: Elsevier, 1996: 465-70.
27. 27 Brown P, Rodgers-Johnson P, Cathala F, et al. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol 1984; 16: 295-304.
28. 28 Billette de Villemeur T, Deslys JP, Pradel A, et al. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996; 47: 690-95.
29. 29 Caraballo AJ. Creutzfeldt-Jakob disease in Venezuela. A case report. Arquivos de Neuro-Psiquiatria 1991; 49: 218-21.
30. 30 Alpers M. Epidemiology and clinical aspects of kuru. In: Prusiner SB, McKinley SB, eds. Prions: novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. San Diego: Academic Press, 1987: 451-65.
31. 31 Trimble ME. Depression and psychosis in neurological practice. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Boston: Butterworth-Heinemann, 1996; 1: 107-18.
32. 32 Will RG. Surveillance of prion diseases in humans. In: Baker HF, Ridley RM, eds. Prion diseases. New Jersey: Humana Press, 1996: 119-37.
33. 33 Will RG, Zeidler M, Brown P, et al. Cerebrospinal fluid test for new-variant Creutzfeldt-Jakob disease. Lancet 1997; 348: 955.
34. 34 Zeidler M, Will RG, Ironside JW, et al. Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease. BMJ 1996; 312: 844.
35. 35 Finkenstaedt M, Szudra A, Zerr I, et al. MR imaging of Creutzfeldt-Jakob disease. Radiology 1996; 199: 793-98.
36. 36 Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-42.
37. 37 Zeidler M, Estibeiro K, Will RG. The genetics of Creutzfeldt-Jakob disease in the United Kingdom. J Neurol Neurosurg Psychiatry 1997; 62: 206.
38. 38 Hunter N, Goldmann W, Smith G, et al. Frequencies of PrP gene variants in healthy cattle and cattle with BSE in Scotland. Vet Record 1994; 135: 400-03.